Marta Hałasa

Magnoflorine—Isolation and the Anticancer Potential against NCI-H1299 Lung, MDA-MB-468 Breast, T98G Glioma, and TE671 Rhabdomyosarcoma Cancer Cells

Estera Okoń, Wirginia Kukuła‐Koch, Marta Hałasa et al. · Biomolecules · 2020 · 39 citations · Full text

Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity—An Isobolographic Analysis

Anna Wawruszak, Jarogniew J. Łuszczki, Joanna Kałafut et al. · International Journal of Molecular Sciences · 2019 · 23 citations · Full text

Additive Pharmacological Interaction, Breast Oncology, Chemoprevention Strategy +17

Synergistic or Additive Pharmacological Interactions between Magnoflorine and Cisplatin in Human Cancer Cells of Different Histological Origin

Estera Okoń, Jarogniew J. Łuszczki, Wirginia Kukuła‐Koch et al. · International Journal of Molecular Sciences · 2020 · 23 citations · Full text

<p>Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties</p>

Anna Wawruszak, Ewelina Gumbarewicz, Estera Okoń et al. · Cancer Management and Research · 2019 · 19 citations · Full text

Combination of Osthole and Cisplatin Against Rhabdomyosarcoma TE671 Cells Yielded Additive Pharmacologic Interaction by Means of Isobolographic Analysis

Agata Jarząb, Jarogniew J. Łuszczki, Małgorzata Guz et al. · Anticancer Research · 2018 · 16 citations · Full text